Toronto-based DionyMed Brands, a multistate cannabis brands operator, said it will acquire the 1.8-acre Los Angeles campus of MM Esperanza 2, also known as MMAC, for $19 million.
The campus includes a dispensary, distribution and manufacturing facilities and a customer-fulfillment center.
In a news release, DionyMed said the deal improves the company’s brands distribution and direct-to-consumer footprint in Southern California.
The acquisition also includes the purchase of other unidentified MMAC assets.
DionyMed, whose U.S. footprint reaches California, Massachusetts, Nevada and Oregon, trades on the Canadian Securities Exchange as DYME.
More details about the deal can be found here.